meta
|
evidence
oncology
Living systematic review and meta-analysis
RET gene alteration defined cancer
2
glioblastoma (GB)
1
immune chekpoint inhibitors
anti-PD-(L)1
nivolumab based treatment
nivolumab alone
pembrolizumab based treatment
pembrolizumab plus SoC
versus all
vs chemotherapy
vs Standard of Care (SoC)
vs VEGF(R) inhibitor
vs bevacizumab based treatment
vs bevacizumab
study list
mapping
overview
meta-analysis
forest plot
NMA
excluded
Study
Exclusion reasons
Remarks
Reference(s)
Empty list - no studies excluded